Recently, The U.S. Food and Drug Administration (FDA) has classified the recall of Neutrogena Makeup Remover Ultra-Soft Cleansing Towelettes as a Class II health risk following the detection of Pluralibacter gergoviae in certain product lots. The bacterial contamination poses a potential infection hazard, especially for individuals with weakened immune systems.
The voluntary recall, initiated by Kenvue Brands LLC on September 19, 2025, affects 1,312 cases of the 25-count plant-based, compostable wipes (LOT 1835U6325A) distributed in Texas, South Carolina, Georgia, and Florida. According to the FDA’s recall database (Event ID 97602, Recall Number C-0001-2026), internal quality testing revealed the presence of Pluralibacter gergoviae, prompting immediate action to remove the affected products from the market.
While no official press release has been issued, the FDA’s Class II designation indicates that use of the contaminated wipes may cause temporary or medically reversible health effects. The case highlights the agency’s continued vigilance over contamination risks in cosmetic and personal care manufacturing. It also reinforces the importance of robust microbiological testing and strict compliance protocols, particularly for products intended for facial and sensitive skin use.
